Plus Therapeutics
PSTV
PSTV
33 hedge funds and large institutions have $40.2M invested in Plus Therapeutics in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
84% less call options, than puts
Call options by funds: $70K | Put options by funds: $434K
Holders
33
Holding in Top 10
–
Calls
$70K
Puts
$434K
Top Buyers
| 1 | +$2.28M | |
| 2 | +$976K | |
| 3 | +$651K | |
| 4 |
GS
Gagnon Securities
New York
|
+$651K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
+$325K |
Top Sellers
| 1 | -$325K | |
| 2 | -$325K | |
| 3 | -$325K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$325K |
| 5 |
Millennium Management
New York
|
-$140K |